Oral treatment with uracil-tegafur, etoposide and leucovorin in non-Asian patients with recurrent non-small cell lung cancer: A non-randomized, phase II study

被引：0
|
作者：
Surmont, V. F.
Aerts, J.
Pouw, E.
Vernhout, R. M.
Gras, E. J.
Tan, K. Y.
Hoogsteden, H.
van Klaveren, R.
机构：
[1] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[2] Amphia Hosp, Breda, Netherlands
[3] Groene Hartziekenhuis, Gouda, Netherlands
[4] St Franciscus Gasthuis, Rotterdam, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19019
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: A non-randomized phase II study
    Surmont, V.
    Aerts, J. G.
    Pouw, E.
    Tan, K. Y.
    Vernhout, R.
    Gras, J.
    Salome, J.
    Pronk, T.
    Schmitz, P. I. M.
    Hoogsteden, H.
    van Klaveren, R. J.
    LUNG CANCER, 2009, 66 (03) : 333 - 337
  • [2] Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer
    Takayama, Koichi
    Kawasaki, Masayuki
    Ninomiya, Kiyoshi
    Motohiro, Akira
    Fujita, Masaki
    Watanabe, Kentaro
    Kajiki, Akira
    Iwami, Fumiyuki
    Miyazaki, Naoki
    Izumi, Miiru
    Hara, Nobuyuki
    Nakanishi, Yoichi
    RESPIROLOGY, 2008, 13 (01) : 103 - 107
  • [3] A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer
    Toyooka, Shinichi
    Okumura, Norihito
    Nakamura, Hiroshige
    Nakata, Masao
    Yamashita, Motohiro
    Tada, Hirohito
    Kajiwara, Shinsuke
    Watanabe, Naoki
    Okada, Morihito
    Sakamoto, Junichi
    Aoe, Motoi
    Soh, Junichi
    Miyoshi, Shinichiro
    Hotta, Katsuyuki
    Matsuo, Keitaro
    Date, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (05) : 699 - 706
  • [4] A multi-center phase III study of carboplatin/paclitaxel versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer
    Toyooka, Shinichi
    Okumura, Norihito
    Nakamura, Hiroshige
    Nakata, Masao
    Yamashita, Motohiro
    Tada, Hirohito
    Kajiwara, Shinsuke
    Watanabe, Naoki
    Okada, Morihito
    Matsuo, Keitaro
    Aoe, Motoi
    Hotta, Katsuyuki
    Sakamoto, Junichi
    Miyoshi, Shinichiro
    Date, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients
    Liang, Sheng-Kai
    Wu, Chang-Wei
    Chang, Ching-, I
    Keng, Li-Ta
    Lee, Meng-Rui
    Wang, Jann-Yuan
    Ko, Jen-Chung
    Liao, Wei-Yu
    Chen, Kuan-Yu
    Ho, Chao-Chi
    Shih, Jin-Yuan
    Yu, Chong-Jen
    CANCER MEDICINE, 2023, 12 (17): : 17993 - 18004
  • [6] Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
    Sánchez, JM
    Balañá, C
    Font, A
    Sánchez, JJ
    Manzano, JL
    Guillot, M
    Margelí, M
    Richardet, M
    Rosell, R
    LUNG CANCER, 2002, 38 (03) : 309 - 315
  • [7] A phase II study of gemcitabine plus oral etoposide (GOE) in treatment of advanced non-small cell lung cancer
    Mok, TSK
    Chan, ATC
    Leung, TWT
    Leung, SF
    Yim, A
    Yeo, W
    Yang, WT
    Wong, HTM
    Chak, K
    Johnson, PJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S255 - S255
  • [8] Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer
    Boyer, MJ
    Mitchell, P
    Goldstein, D
    Millward, MJ
    Olver, IN
    Clarke, SJ
    Richardson, G
    Davis, I
    LUNG CANCER, 2001, 32 (01) : 89 - 94
  • [9] A PHASE III STUDY OF CARBOPLATIN/PACLITAXEL VERSUS ORAL URACIL-TEGAFUR AS THE ADJUVANT CHEMOTHERAPY IN RESECTED NON-SMALL CELL LUNG CANCER (NSCLC) - CONDUCTED BY SETOUCHI LUNG CANCER GROUP (SLCG)
    Okumura, Norihito
    Toyooka, Shinichi
    Nakamura, Hiroshige
    Nakata, Masao
    Yamashita, Motohiro
    Hirohito, Tada
    Kajiwara, Shinsuke
    Watanabe, Naoki
    Okada, Morihito
    Sakamoto, Junichi
    Aoe, Motoi
    Miyoshi, Shinichiro
    Date, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1320 - S1320
  • [10] The Role of Oral Etoposide in Non-Small Cell Lung Cancer
    Robert L. Comis
    David M. Friedland
    Barbara C. Good
    Drugs, 1999, 58 : 21 - 30
12345